CRISPR/Cas9 nuclease cleavage combined with Gibson assembly for seamless cloning

被引:72
|
作者
Wang, Jia-Wang [1 ]
Wang, Amy [1 ]
Li, Kunyu [1 ]
Wang, Bangmei [1 ]
Jin, Shunqian [2 ,3 ]
Reiser, Michelle [1 ]
Lockey, Richard F. [1 ,4 ]
机构
[1] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33620 USA
[2] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] James A Haley Vet Hosp, Tampa, FL USA
关键词
CRISPR cleavage; Gibson cloning; large vector; Cas9; single guide RNA; TARGETED MUTAGENESIS; IN-VITRO; RNA; DNA; GENERATION; SPECIFICITY; DROSOPHILA; MULTIPLEX; LIGATION;
D O I
10.2144/000114261
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Restriction enzymes have two major limitations for cloning: they cannot cleave at any desired location in a DNA sequence and may not cleave uniquely within a DNA sequence. In contrast, the clustered regularly interspaced short palindromic repeat (CRISPR)-associated enzyme 9 (Cas9), when coupled with single guide RNAs (sgRNA), has been used in vivo to cleave the genomes of many species at a single site, enabling generation of mutated cell lines and animals. The Cas9/sgRNA complex recognizes a 17-20 base target site, which can be of any sequence as long as it is located 5' of the protospacer adjacent motif (PAM; sequence 5'-NRG, where R = G or A). Thus, it can be programmed to cleave almost anywhere with a stringency higher than that of one cleavage in a sequence of human genome size. Here, the Cas9 enzyme and a specific sgRNA were used to linearize a 22 kb plasmid in vitro. A DNA fragment was then inserted into the linearized vector seamlessly through Gibson assembly. Our technique can be used to directly, and seamlessly, clone fragments into vectors of any size as well as to modify existing constructs where no other methods are available.
引用
收藏
页码:161 / 170
页数:7
相关论文
共 50 条
  • [1] Application of CRISPR/Cas9 Nuclease in Amphioxus Genome Editing
    Su, Liuru
    Shi, Chenggang
    Huang, Xin
    Wang, Yiquan
    Li, Guang
    GENES, 2020, 11 (11) : 1 - 9
  • [2] Programmable RNA recognition and cleavage by CRISPR/Cas9
    Mitchell R. O’Connell
    Benjamin L. Oakes
    Samuel H. Sternberg
    Alexandra East-Seletsky
    Matias Kaplan
    Jennifer A. Doudna
    Nature, 2014, 516 : 263 - 266
  • [3] Programmable RNA recognition and cleavage by CRISPR/Cas9
    O'Connell, Mitchell R.
    Oakes, Benjamin L.
    Sternberg, Samuel H.
    East-Seletsky, Alexandra
    Kaplan, Matias
    Doudna, Jennifer A.
    NATURE, 2014, 516 (7530) : 263 - +
  • [4] Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease
    Doetschman, Thomas
    Georgieva, Teodora
    CIRCULATION RESEARCH, 2017, 120 (05) : 876 - 894
  • [5] CRISPR/Cas9
    杨丽
    中南医学科学杂志, 2016, 44 (05) : 585 - 585
  • [6] CRISPR/Cas9
    Mizuno, Naoaki
    Mizutani, Eiji
    Sato, Hideyuki
    Kasai, Mariko
    Nakauchi, Hiromitsu
    Yamaguchi, Tomoyuki
    BIO-PROTOCOL, 2019, 9 (13):
  • [7] Conformational control of DNA target cleavage by CRISPR–Cas9
    Samuel H. Sternberg
    Benjamin LaFrance
    Matias Kaplan
    Jennifer A. Doudna
    Nature, 2015, 527 : 110 - 113
  • [8] CRISPR/Cas9 nuclease cleavage enables marker-free genome editing in Escherichia coli: A sequential study
    Ng, I-Son
    Hung, Ying-Hsin
    Kao, Pei-Hsun
    Zhou, Yunli
    Zhang, Xia
    JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2016, 68 : 31 - 39
  • [9] CRISPR/Cas9 nuclease-mediated targeting in marmosets, rats and mice
    Zhou, Yang
    Baweke, Lenegereshe
    Dallstream, Alice
    Vasudevan, Kuzhalini
    Paulson, Madeline
    Feng, Guoping
    Pickel, Jim
    TRANSGENIC RESEARCH, 2014, 23 (05) : 882 - 883
  • [10] Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
    Johnson, Matthew J.
    Laoharawee, Kanut
    Lahr, Walker S.
    Webber, Beau R.
    Moriarity, Branden S.
    SCIENTIFIC REPORTS, 2018, 8